Perceptive Advisors - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 20 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2016$369,000
-35.4%
75,0000.0%0.03%
-23.8%
Q4 2015$571,000
-48.7%
75,000
-50.0%
0.04%
-6.7%
Q3 2015$1,114,000
+47.5%
150,000
+100.0%
0.04%0.0%
Q2 2015$755,000
+6.9%
75,0000.0%0.04%
-18.2%
Q1 2015$706,000
+62.3%
75,0000.0%0.06%
+52.8%
Q4 2014$435,000
-32.6%
75,0000.0%0.04%
-47.8%
Q3 2014$645,000
-11.8%
75,0000.0%0.07%
-4.2%
Q2 2014$731,000
-15.0%
75,0000.0%0.07%
-20.0%
Q1 2014$860,00075,0000.09%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2014
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders